Global Cephalic Disorders Treatment Market Insights, Trends & Future Development Status Recorded during 2018-2028 / Key manufacturers Widex A/S, Oticon, Abbott Laboratories, GlaxoSmithKline plc, Novartis International AG, Sanofi S.A., Pfizer Inc., Takeda
Brochure of this Report- www.factmr.com/connectus/sample?flag=B&rep_id=1308
Cephalic disorders are congenital conditions characterized by damage or abnormal development of the nervous system. They are caused by multiple factors such as genetic, nutritional deficiencies and environmental exposure to infection or radiation during gestation. Cephalic disorders result in chronic, disabling disorders and even death. Common cephalic disorders include anencephaly, colpocephaly, holoprosencephaly, ethmocephaly, hydranencephaly, iniencephaly, lissencephaly, megalencephal, microcephaly, porencephaly, and schizencephaly. Anencephaly accounts for the largest share of cephalic disorders with almost 1,000 to 2,000 babies born with anencephaly each year in the U.S. The treatment for cephalic disorders includes drugs, surgery and occupational and behavioral therapy. However, there is a dearth of curative treatment and most patients receive symptomatic treatments based on conditions that vary by a large degree.
Tax incentives, grants for research and other provisions by governments for rare diseases are other factors driving the cephalic disorder treatment market growth. For example, under the Orphan Drug Act (ODA), economic incentives such as grants to academic-based researchers or companies are awarded for research. The government of UA also provides 50 % tax credit for expenditures incurred for clinical testing for orphan drugs. The Food and Drug Administration (FDA) also provides a 7-year market exclusivity for orphan diseases. ORPHANET, a consortium of 40 countries, is another initiative led by European countries. It lists isolated anencephaly, absence of innominate vein, holoprosencephaly and others cephalic disorders for grant benefits.
The development of healthcare infrastructure and per capita income is another trend driving the global cephalic disorders treatment market. Rising awareness and development in technologies such as genetic testing and surgery are driving faster market adoption for the global cephalic disorders treatment market.
To know more about the Cephalic Disorders Treatment Market Visit the link- www.factmr.com/report/1308/cephalic-disorders-treatment-m...
Poor efficacy and efficiency of treatment, risk of infection, poor success rates, high cost of treatment and absence of curative treatment for many cephalic disorders are expected to restraint the growth of the cephalic disorders treatment market.
The global market for cephalic disorders treatment is consolidated with a few large players dominating the scene. Most of the treatment is symptomatic and there is a dearth of curative treatment. Thus, any drug – even if partial curative – will be a block buster with rapid adoption and minimum marketing cost. A large opportunity exists in the hearing aids devices market and some of the established players in the global cephalic disorders treatment include Sonova Holding AG, Widex A/S, Oticon, Abbott Laboratories, GlaxoSmithKline plc, Novartis International AG, Sanofi S.A., Pfizer Inc., Takeda Pharmaceutical Company Ltd., and others.
Cephalic Disorders Treatment Market: Regional-Wise Outlook
The global cephalic disorders treatment market is classified into regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific excluding Japan (APEJ), Japan, Middle East and Africa. North America is expected to account for the largest share of the global cephalic disorders treatment market, owing to an excellent reimbursement rate, large healthcare expenditure amounting to 16 % of GDP in 2016 and compulsory screening under the affordable healthcare act. The provision of fast track approval by the FDA is expected to drive greater research in the area.
The Asia Pacific cephalic disorders treatment market is dominated by China and India and is expected to grow with the fastest CAGR, owing to the expansion of the healthcare industry and economic growth. Western Europe is expected to account for the second largest market, led by Germany, France and the U.K. The European cephalic disorders treatment market is expected to grow at a significant rate, owing to the incentives by European Council. The Middle East and Africa cephalic disorders treatment market is expected to be skewed in favor of the gulf economies of Saudi Arabia, Kuwait, and Qatar.
Cephalic Disorders Treatment Market: Key Players
Some of the major players operating in the global cephalic disorders treatment market include Sonova Holding AG, Widex A/S, Oticon, Abbott Laboratories, GlaxoSmithKline plc, Novartis International AG, Sanofi S.A., Pfizer Inc., Takeda Pharmaceutical Company Ltd. and others.
The global cephalic disorders treatment market is characterized by the absolute dearth of effective and curative treatment. Thus, research and development provides the largest market opportunity and any degree of success will lead to monopoly with an extremely large premium. Thus, partnership with large hospitals and organizations is an attractive strategy to eliminate the large development cost of drug research.
The global cephalic disorders treatment report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Request TOC of this Report- www.factmr.com/connectus/sample?flag=T&rep_id=1308
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.
11140 Rockville Pike
Rockville, MD 20852
Read Industry News at - www.industrynewsanalysis.com/
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Cephalic Disorders Treatment Market Insights, Trends & Future Development Status Recorded during 2018-2028 / Key manufacturers Widex A/S, Oticon, Abbott Laboratories, GlaxoSmithKline plc, Novartis International AG, Sanofi S.A., Pfizer Inc., Takeda here
News-ID: 1481486 • Views: 139
More Releases from Fact.MR
Imminence of New Gonorrhea Therapeutic Drugs is Evident as the Bacteria Grow ‘ …
According to a new study of FactMR, the gonorrhea therapeutics market will reach ~US$ 970 Mn in 2019, and estimated to register a 4% Y-o-Y over 2018. The gonorrhea therapeutics industry will remain influenced by increased attention on new developments in novel therapeutic compounds or antimicrobials for improving the success potential of future treatment. There has been a significant rise in the prevalence of gonorrhea that is resistant to components of
Motorcycle Market Projected to Witness a Single-Digit CAGR During 2017 to 2026 | …
In order to dissert the market scenario prevailing across the motorcycle market sector, FactMR has evenly presented a comprehensive motorcycle market analysis to its extensive online repository. With all vital market facets enclosed into this single assessment, readers can learn about different market drivers, opportunities and trends which are likely to influence the overall market space for the motorcycle market in the coming years. In addition, factors such as market
Comprehensive Research Report on Global Motorcycle Accessories Market until the …
In order to dissert the market scenario prevailing across the motorcycle accessories market sector, FactMR has evenly presented a comprehensive motorcycle accessories industry analysis to its extensive online repository. With all vital market facets enclosed into this single assessment, readers can learn about different market drivers, opportunities and trends which are likely to influence the overall market space for the motorcycle accessories market in the coming years. In addition, factors
Functional Workwear Apparel Market Investigation and Growth Forecasted until the …
According to the latest report by Fact.MR, the global functional workwear apparel market is expected to witness sluggish growth. The market is estimated to increase to 2.6% CAGR during the forecast period 2017-2026. The market is also projected to bring in US$ 749.3 million revenue by the end of 2026. Owing to the rise in industrial and service sector, companies are moving towards providing workwear apparel offering safety, comfortability, thereby